Tata India Pharma & Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8161 Cr | ₹1208 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 21% | 26.49% |
Expense Ratio | 1.82 | 2.14 |
Manager | Sailesh Raj Bhan | Meeta Shetty |
ISIN Code | INF204K01968 | INF277K016A9 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 3.67% | 5.08% |
6 Month | -6.69% | -6.68% |
1 Year | 14.96% | 15.91% |
3 Year | 18.1% | 18.52% |
5 Year | 22.53% | 22.13% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | -1.18% | -1.3% |
1 Year | 1.14% | 1.32% |
3 Year | 23.16% | 24.14% |
5 Year | 19.24% | 19.77% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 18.19% | 7.82% |
3 Year | 20.5% | 17.79% |
5 Year | 20.36% | 14.55% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 15.623% | 16.538% |
Sharp | 0.707% | 0.681% |
Beta | 0.908% | 0.969% |
Alpha | 0.486% | 0.018% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Meeta Shetty |
Total AUM | ₹96086 Cr | ₹17847 Cr |
Funds Managed | 5 | 5 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.36 | 5.06 |
Large Cap | 38.72 | 35.26 |
Mid Cap | 32.78 | 31.87 |
Small Cap | 27.14 | 27.82 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.36 | 4.34 |
Healthcare | 98.64 | 93.44 |
Basic Materials | - | 2.22 |
Top Comparisons
BANDHAN Equity Savings Fund - Regular Plan - Growth
3Y Returns7.18%
DSP Equity Savings Fund - Regular Plan - Growth
3Y Returns9.78%
ICICI Prudential Global Advantage Fund (FOF) - Growth Option
3Y Returns6.63%
HDFC Income Plus Arbitrage Active FOF - Growth
3Y Returns12.63%
LIC MF Ultra Short Term Fund Regular - Growth
3Y Returns6.12%
Mirae Asset Ultra Short Duration Fund Regular Growth
3Y Returns6.92%
ICICI Prudential Large & Mid Cap Fund - Growth
3Y Returns19.73%
Axis Growth Opportunities Fund - Regular Plan - Growth
3Y Returns13.19%